Global Epilepsy Therapeutics Market–our new study reveals trends, R&D progress, and predicted revenues
Where is the Global Epilepsy Therapeutics market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2031, assessing data, trends, opportunities and business prospects there.
Discover how to stay ahead
Our 210-page report provides 170 tables and 203 charts/graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at the overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Global Epilepsy Market. See how to exploit the opportunities.
Forecasts to 2031 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2031, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets
By Drug Class
• First Generation Drugs
• Second Generation Drugs
• Third Generation Drugs
By Distribution Channel
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 14 leading national markets:
• North America
• U.S.
• Canada
• Europe
• United Kingdom
• Germany
• France
• Italy
• Spain
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Rest of Latin America
• Middle East and Africa
• GCC
• South Africa
• Rest of Middle East and Africa
Need industry data? Please contact us today.
The report also includes profiles and for some of the leading companies in the Global Epilepsy Therapeutics Market, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
Overall world revenue for Epilepsy Therapeutics Market will surpass $xx billion in 2021, our work calculates. We predict strong revenue growth through 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Global Epilepsy Therapeutics Market report helps you
In summary, our 210-page report provides you with the following knowledge:
• Revenue forecasts to 2031 for Global Epilepsy Therapeutics Market, with forecasts for Drug Type, and Distribution Channel, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2031 for 5 regional and 14 key national markets – See forecasts for the Global Epilepsy Therapeutics market in North America, Europe, Asia-Pacific, Latin America and Middle East Asia. Also forecasted is the market in the US, Canada, Brazil, Germany, France, UK, Italy, Spain, China, India, Japan, and South Africa among other prominent economies.
• Prospects for established firms and those seeking to enter the market– including company profiles for the major companies involved in the Global Epilepsy Therapeutics Market. Some of the companies profiled in this report include UCB Pharma, Pfizer, Eisai, Inc., GSK, GW Pharma, Ranbaxy and Sanofi.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Global Epilepsy Therapeutics Market and leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Epilepsy Therapeutics Market Report 2021-2031: Forecasts by Drugs Type (First Generation Drugs, Second Generation Drugs, Third Generation Drugs), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1 Introduction to Global Epilepsy Therapeutics Market
1.2 Global Epilepsy Therapeutics Market Definition
1.3 Why You Should Read This Report
1.4 What This Report Delivers
1.5 Key Questions Answered By This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Primary Research
1.7.2 Secondary Research
1.7.3 Market Evaluation & Forecasting Methodology
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2. Executive Summary
3. Global Epilepsy Therapeutics Market Dynamics
3.1 Epilepsy Therapeutics Market Drivers
3.1.1 High Incidence of Epilepsy associated With Ever Rising Geriatric Population
3.1.2 Rising Disposable Income & Effective Funding to drive the market growth
3.1.3 Health Insurance Reforms
3.2 Epilepsy Therapeutics Market Restraint
3.2.1 Treatment Gap
3.2.2 Shortage of staff
3.3 Epilepsy Therapeutics Market Opportunities
3.3.1 Novel Epilepsy Drugs
3.3.2 New era of personalized treatment for epilepsy management
3.4 Epilepsy Therapeutics Market Challenges
3.4.1 Limited access to antiseizure medicines due to high cost of drugs
3.4.2 Lack of knowledge, misperceptions and stigma
3.5 SWOT Analysis
3.5.1 Strength
3.5.2 Weakness
3.5.3 Opportunity
3.5.4 Threat
3.6 Porter’s Five Forces Analysis
3.6.1 Threat of New Entrants (Low)
3.6.2 Bargaining power of buyers
3.6.3 Bargaining power of suppliers
3.6.4 Threat of substitutes
3.6.5 Threat of competition
3.5 PESTLE Analysis
3.5.1 Political Factors
3.5.2 Economic Factors
3.5.3 Social Factors
3.5.4 Technological Factors
3.4.5 Legal Factors
3.4.6 Environmental Factors
4. Global Epilepsy Therapeutics Market Size
4.1 Market Analysis of Global Epilepsy Therapeutics
4.1.1 Global Epilepsy Therapeutics Market, By Covid Recovery (V, U, W, L)
4.2 Market Analysis of Epilepsy Therapeutics, by Drug Class
4.2.1 First Generation Drugs
4.2.2 Second Generation Drugs
4.2.3 Third Generation Drugs
5. Global Epilepsy Therapeutics Market Share, By Distribution Channel
5.1 Hospital Pharmacy
5.1.1 Pre-COVID Global Epilepsy Therapeutics Market, By Hospital Pharmacy
5.1.2 Global Epilepsy Therapeutics Market, By Hospital Pharmacy, COVID Recovery (V, U, W& L)
5.2 Retail Pharmacy
5.2.1 Pre-COVID Global Epilepsy Therapeutics Market, By Hospital Pharmacy
5.2.2 Global Epilepsy Therapeutics Market, By Retail Pharmacy, COVID Recovery (V, U, W& L)
5.3 Online Pharmacy
5.3.1 Pre-COVID Global Epilepsy Therapeutics Market, By Hospital Pharmacy
5.3.2 Global Epilepsy Therapeutics Market, By Hospital Pharmacy, COVID Recovery (V, U, W& L)
6. Global Epilepsy Therapeutics Market Share, By Geography
6.1 North America
6.1.1 Pre-COVID Epilepsy Therapeutics Market, North America
6.1.2 North America Epilepsy Therapeutics Market, COVID Recovery (V, U, W& L)
6.1.3 North America epilepsy therapeutics market, by country
6.1.4 US
6.1.5 Canada
6.2 Europe
6.2.1 Pre-COVID Epilepsy Therapeutics Market, Europe
6.2.2 Europe Epilepsy Therapeutics Market, COVID Recovery (V, U, W& L)
6.2.3 Europe epilepsy therapeutics market, by country
6.2.4 UK
6.2.5 Germany
6.2.6 France
6.2.7 Italy
6.2.8 Spain
6.2.9 Rest of Europe
6.3 Asia-Pacific
6.3.1 Pre-COVID Epilepsy Therapeutics Market, Asia-Pacific
6.3.2 Asia-Pacific Epilepsy Therapeutics Market, COVID Recovery (V, U, W& L)
6.3.3 Asia-Pacific epilepsy therapeutics market, by country
6.3.4 China
6.3.5 Japan
6.3.6 India
6.3.7 Rest of APAC
6.4 Latin America
6.4.1 Pre-COVID Epilepsy Therapeutics Market, Latin America
6.4.2 Latin America Epilepsy Therapeutics Market, COVID Recovery (V, U, W& L)
6.3.3 Latin America epilepsy therapeutics market, by country
6.4.4 Brazil
6.4.5 Mexico
6.4.6 Rest of Latin America
6.5 Middle East and Africa
6.5.1 Pre-COVID Epilepsy Therapeutics Market, MEA
6.5.2 MEA Epilepsy Therapeutics Market, COVID Recovery (V, U, W& L)
6.5.3 Middle East and Africa Epilepsy Therapeutics market, by country
6.5.4 GCC
6.5.5 South Africa
6.5.6 Rest of MEA
7. Regulations, Key Mergers and Acquisitions and Pipeline Analysis
7.1 Regulations
7.2 Key Acquisitions
7.3 New Drug Launches and Approvals
7.4 Pipeline Analysis
8. Market Share Analysis of key Players Anti-Epileptic Drugs
9. Company Profiles
9.1 UCB Pharma
9.1.1 Company Snapshot
9.1.2 Company Overview
9.1.3 Future Outlook
9.1.4 Financial Analysis
9.1.5 Product Benchmarking
9.2 Pfizer
9.2.1 Company Snapshot
9.2.2 Company Overview
9.2.3 Future Outlook
9.2.4 Financial Analysis
9.2.5 Products Benchmarking
9.3 Eisai, Inc.
9.3.1 Company Snapshot
9.3.2 Company Overview
9.3.3 Future Outlook
9.3.4 Financial Analysis
9.3.5 Product Benchmarking
9.4 GlaxoSmithKline (GSK)
9.4.1 Company Snapshot
9.4.2 Company Overview
9.4.3 Future Outlook
9.4.4 Product Benchmarking
9.4.5 Financials
9.5 GW Pharma
9.5.1 Company Snapshot
9.5.2 Company Overview
9.5.3 Future Outlook
9.5.4 Product Benchmarking
9.5.5 Financials
9.6 Ranbaxy (Acquired by Sun Pharma)
9.6.1 Company Snapshot
9.6.2 Company Overview
9.6.3 Future Outlook
9.6.4 Product Benchmarking
9.6.5 Financials
9.7 Sanofi
9.7.1 Company Snapshot
9.7.2 Company Overview
9.7.3 Future Outlook
9.7.4 Product Benchmarking
9.7.5 Financials
10. Conclusions
10.1 Concluding Remarks From Visiongain
10.2 Recommendation for Market Players
10.3 Leading Region and Fastest Growing Region
10.4 Market Entry
LIST OF TABLES
Table 1 Global Epilepsy Therapeutics Market Snapshot, 2021 & 2031 (US$ billion, CAGR %)
Table 2 Global Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%)
Table 3 Global Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Table 4 Global Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Table 5 Global Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Table 6 Global Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Table 7 Global First-Generation Drugs Market (2021-2031), (USD Billion), AGR%, CAGR%
Table 8 Global First-Generation Drugs Market, (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Table 9 Global First-Generation Drugs Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Table 10 Global First-Generation Drugs Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Table 11 Global First-Generation Drugs Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Table 12 Global Second-Generation Drugs Market (2021-2031), by Type, (USD Billion), AGR%, CAGR%
Table 13 Global Second-Generation Drugs Market (2021-2031), by Type, (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Table 14 Global Second-Generation Drugs Market (2021-2031), by Type, (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Table 15 Global Second-Generation Drugs Market (2021-2031), by Type, (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Table 16 Global Second Generation Drugs Market (2021-2031), by Type, (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Table 17 Global Third Generation Drugs Market (2021-2031), by Type, (USD Billion), AGR%, CAGR%
Table 18 Global Third Generation Drugs Market (2021-2031), by Type, (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Table 19 Global Third Generation Drugs Market (2021-2031), by Type, (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Table 20 Global Third Generation Drugs Market (2021-2031), by Type, (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Table 21 Global Third Generation Drugs Market (2021-2031), by Type, (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Table 22 Global Epilepsy Therapeutics Market ($Bn) 2021-2031, By Distribution Channel
Table 23 Global Epilepsy Therapeutics Market ($Bn) 2021-2031, By Hospital Pharmacy
Table 24 Global Epilepsy Therapeutics Market ($Bn) 2021-2031, By Hospital Pharmacy (V-Shaped)
Table 25 Global Epilepsy Therapeutics Market ($Bn) 2021-2031, By Hospital Pharmacy (U-Shaped)
Table 26 Global Epilepsy Therapeutics Market ($Bn) 2021-2031, By Hospital Pharmacy (L-Shaped)
Table 27 Global Epilepsy Therapeutics Market ($Bn) 2021-2031, By Hospital Pharmacy (W-Shaped)
Table 28 Global Epilepsy Therapeutics Market ($Bn) 2021-2031, By Retail Pharmacy
Table 29 Global Epilepsy Therapeutics Market ($Bn) 2021-2031, By Retail Pharmacy (V-Shaped)
Table 30 Global Epilepsy Therapeutics Market ($Bn) 2021-2031, By Retail Pharmacy (U-Shaped)
Table 31 Global Epilepsy Therapeutics Market ($Bn) 2021-2031, By Retail Pharmacy (L-Shaped)
Table 32 Global Epilepsy Therapeutics Market ($Bn) 2021-2031, By Retail Pharmacy (W-Shaped)
Table 33 Global Epilepsy Therapeutics Market ($Bn) 2021-2031, By Online Pharmacy
Table 34 Global Epilepsy Therapeutics Market ($Bn) 2021-2031, By Online Pharmacy (V-Shaped)
Table 35 Global Epilepsy Therapeutics Market ($Bn) 2021-2031, By Online Pharmacy (U-Shaped)
Table 36 Global Epilepsy Therapeutics Market ($Bn) 2021-2031, By Online Pharmacy (L-Shaped)
Table 37 Global Epilepsy Therapeutics Market ($Bn) 2021-2031, By Online Pharmacy (W-Shaped)
Table 38 Global Epilepsy Therapeutics Market ($Bn) 2021-2031, By Region
Table 39 North America Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%
Table 40 North America Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%, (V-Shaped Recovery)
Table 41 North America Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Table 42 North America Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Table 43 North America Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Table 44 North America Epilepsy Therapeutics Market ($Bn) 2021-2031
Table 45 USA Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%
Table 46 US Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Table 47 US Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Table 48 US Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Table 49 US Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Table 50 Canada Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%
Table 51 Canada Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Table 52 Canada Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Table 53 Canada Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Table 54 Canada Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Table 55 Europe Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%
Table 56 Europe Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Table 57 Europe Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Table 58 Europe Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Table 59 Europe Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Table 60 Europe Epilepsy Therapeutics Market (2021-2031) (USD Billion), 2021-2031
Table 61 UK Protein Labelling Reagents RUO Market (2021-2031) (USD Billion), AGR%, CAGR%
Table 62 UK Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Table 63 UK Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Table 64 UK Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Table 65 UK Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Table 66 Germany Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%
Table 67 Germany Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Table 68 Germany Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Table 69 Germany Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Table 70 Germany Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Table 71 France Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%
Table 72 France Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Table 74 France Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Table 75 France Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Table 76 France Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Table 77 Italy Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%
Table 78 Italy Epilepsy Therapeutics Market (2021-2031) (USD Bn), AGR%, CAGR%, (V-Shaped Recovery)
Table 79 Italy Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Table 80 Italy Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Table 81 Italy Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Table 82 Spain Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%
Table 83 Spain Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Table 84 Spain Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Table 85 Spain Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Table 86 Spain Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Table 87 Rest of Europe Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%
Table 88 Rest of Europe Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Table 89 Rest of Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Table 90 Rest of Europe Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Table 91 Rest of Europe Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Table 92 Asia-Pacific Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%)
Table 93 Asia-Pacific Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Table 94 Asia-Pacific Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Table 95 Asia-Pacific Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Table 96 Asia-Pacific Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Table 97 Asia-Pacific Epilepsy Therapeutics Market ($Bn) 2021-2031
Table 98 China Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%
Table 99 China Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Table 100 China Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Table 101 China Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Table 102 China Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Table 103 Japan Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%
Table 104 Japan Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Table 105 Japan Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Table 106 Japan Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Table 107 Japan Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Table 108 India Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%
Table 109 India Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Table 110 India Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Table 111 India Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Table 112 India Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Table 113 Rest of APAC Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%
Table 114 Rest of APAC Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Table 115 Rest of APAC Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Table 116 Rest of APAC Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Table 117 Rest of APAC Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Table 118 Latin America Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%)
Table 119 Latin America Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Table 120 Latin America Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Table 121 Latin America Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Table 122 Latin America Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Table 123 Latin America Epilepsy Therapeutics Market ($Bn) 2021-2031
Table 124 Brazil Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%
Table 125 Brazil Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Table 126 Brazil Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Table 127 Brazil Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Table 128 Brazil Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Table 129 Mexico Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%
Table 130 Mexico Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Table 131 Mexico Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Table 132 Mexico Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Table 133 Mexico Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Table 134 Rest of Latin America Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%
Table 135 Rest of Latin America Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Table 136 Rest of Latin America Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Table 137 Rest of Latin America Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Table 138 Rest of Latin America Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Table 139 MEA Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%)
Table 140 MEA Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Table 141 MEA Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Table 142 MEA Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Table 143 MEA Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Table 144 Middle East and Africa Epilepsy Therapeutics Market ($Bn) 2021-2031
Table 145 GCC Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%
Table 146 GCC Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Table 147 GCC Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Table 148 GCC Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Table 149 GCC Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Table 150 South Africa Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%
Table 151 South Africa Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Table 152 South Africa Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Table 153 South Africa Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Table 154 South Africa Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Table 155 Rest of MEA Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%
Table 156 Rest of MEA Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Table 157 Rest of MEA Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Table 158 Rest of MEA Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Table 159 Rest of MEA Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Table 160 Recent Acquisitions in AED Market
Table 161 New ant-epileptic drug launches and approvals
Table 162 Pipeline Analysis
Table 163 Global Market Shares for Key Competitors of Anti-Epileptic Drugs Market, 2020
Table 164 UCB Pharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 165 Pfizer: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 166 Eisai, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 167 GlaxoSmithKline: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 168 GW Pharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 169 Ranbaxy: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 170 Sanofi: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
List of Figures
Figure 1 Global Epilepsy Therapeutics Market Segmentation
Figure 2 Global Epilepsy Therapeutics RUO Market: Market Trends
Figure 3 Global Epilepsy Therapeutics Market: SWOT Analysis
Figure 4 Global Epilepsy Therapeutics Market: Porter’s Five Forces Analysis
Figure 5 Global Epilepsy Therapeutics Market: PESTLE Analysis
Figure 6 Global Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%)
Figure 7 Global Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Figure 8 Global Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Figure 9 Global Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Figure 10 Global Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Figure 11 Global Epilepsy Therapeutics utilization
Figure 12 Global Protein Labelling Reagents for Research Use Only (RUO) Market, By Type, 2021, 2026, 2031 (%)
Figure 13 Global First-Generation Drugs Market (2021-2031) (USD Billion), AGR%, CAGR%)
Figure 14 Global First-Generation Drugs Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Figure 15 Global First Generation Drugs Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Figure 16 Global First Generation Drugs Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Figure 17 Global First-Generation Drugs Market (2021-2031) (USD Billion), AGR%, CAGR%), (W--Shaped Recovery)
Figure 18 Global Second Generation Drugs Market (2021-2031), by Type, (USD Billion), AGR%, CAGR%
Figure 19 Global Second Generation Drugs Market (2021-2031), by Type, (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Figure 20 Global Second Generation Drugs Market (2021-2031), by Type, (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Figure 21 Global Second Generation Drugs Market (2021-2031), by Type, (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Figure 22 Global Second Generation Drugs Market (2021-2031), by Type, (USD Billion), AGR%, CAGR%), (W--Shaped Recovery)
Figure 23 Global Third Generation Drugs Market (2021-2031), by Type, (USD Billion), AGR%, CAGR%
Figure 24 Global Third Generation Drugs Market (2021-2031), by Type, (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Figure 25 Global Third Generation Drugs Market (2021-2031), by Type, (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Figure 26 Global Third Generation Drugs Market (2021-2031), by Type, (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Figure 27 Global Third Generation Drugs Market (2021-2031), by Type, (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Figure 28 Global Epilepsy Therapeutics Market, By Drug Class, 2021, 2026, 2031 (%)
Figure 29 Global Epilepsy Therapeutics Market ($Bn) 2021-2031, By Hospital Pharmacy
Figure 30 Global Epilepsy Therapeutics Market ($Bn) 2021-2031, By Hospital Pharmacy (V-Shaped)
Figure 31 Global Epilepsy Therapeutics Market ($Bn) 2021-2031, By Hospital Pharmacy (U-Shaped)
Figure 32 Global Epilepsy Therapeutics Market ($Bn) 2021-2031, By Hospital Pharmacy (L-Shaped)
Figure 33 Global Epilepsy Therapeutics Market ($Bn) 2021-2031, By Hospital Pharmacy (W-Shaped)
Figure 34 Global Epilepsy Therapeutics Market ($Bn) 2021-2031, By Retail Pharmacy
Figure 35 Global Epilepsy Therapeutics Market ($Bn) 2021-2031, By Retail Pharmacy (V-Shaped)
Figure 36 Global Epilepsy Therapeutics Market ($Bn) 2021-2031, By Retail Pharmacy (U-Shaped)
Figure 37 Global Epilepsy Therapeutics Market ($Bn) 2021-2031, By Retail Pharmacy (L-Shaped)
Figure 38 Global Epilepsy Therapeutics Market ($Bn) 2021-2031, By Retail Pharmacy (W-Shaped)
Figure 39 Global Epilepsy Therapeutics Market ($Bn) 2021-2031, By Online Pharmacy
Figure 40 Global Epilepsy Therapeutics Market ($Bn) 2021-2031, By Online Pharmacy (V-Shaped)
Figure 41 Global Epilepsy Therapeutics Market ($Bn) 2021-2031, By Online Pharmacy (U-Shaped)
Figure 42 Global Epilepsy Therapeutics Market ($Bn) 2021-2031, By Online Pharmacy (L-Shaped)
Figure 43 Global Epilepsy Therapeutics Market ($Bn) 2021-2031, By Online Pharmacy (W-Shaped)
Figure 44 Mean number of people with epilepsy per 1000 population
Figure 45 Global Epilepsy Therapeutics Market, By Geography, 2021, 2026, 2031 (%)
Figure 46 Global Epilepsy Therapeutics Market Share, By Geography, %
Figure 47 North America Epilepsy Therapeutics Market, by anti-epileptic drugs
Figure 48 North America Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%
Figure 49 North America Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Figure 50 North America Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Figure 51 North America Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Figure 52 North America Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W--Shaped Recovery)
Figure 53 North America Epilepsy Therapeutics Market, 2021, 2026, 2031 (%)
Figure 54 USA Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%
Figure 55 US Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Figure 56 US Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Figure 57 US Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Figure 58 US Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Figure 59 Canada Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%
Figure 60 Canada Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Figure 61 Canada Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Figure 62 Canada Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Figure 63 Canada Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Figure 64 Europe Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%
Figure 65 Europe Epilepsy Therapeutics Market, by Type
Figure 66 Europe Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Figure 67 Europe Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Figure 68 Europe Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Figure 69 Europe Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W--Shaped Recovery)
Figure 70 Europe Epilepsy Therapeutics Market, 2021, 2026, 2031 (%)
Figure 71 UK Protein Labelling Reagents RUO Market (2021-2031) (USD Billion), AGR%, CAGR%
Figure 72 UK Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Figure 73 UK Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Figure 74 UK Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Figure 75 UK Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Figure 76 Germany Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%
Figure 77 Germany Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Figure 78 Germany Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Figure 79 Germany Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Figure 80 Germany Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Figure 81 France Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%
Figure 82 France Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Figure 83 France Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Figure 84 France Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Figure 85 France Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Figure 86 Italy Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%
Figure 87 Italy Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Figure 88 Italy Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Figure 89 Italy Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Figure 90 Italy Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Figure 91 Spain Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%
Figure 92 Spain Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Figure 93 Spain Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Figure 94 Spain Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Figure 95 Spain Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Figure 96 Rest of Europe Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%
Figure 97 Rest of Europe Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Figure 98 Rest of Europe Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Figure 99 Rest of Europe Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Figure 100 Rest of Europe Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Figure 101 Asia-Pacific Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%)
Figure 102 Asia-Pacific Epilepsy Therapeutics Market, by Type
Figure 103 Asia- Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Figure 104 Asia-Pacific Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Figure 105 Asia-Pacific Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Figure 106 Asia-Pacific Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W--Shaped Recovery)
Figure 107 Asia Pacific Epilepsy Therapeutics Market, 2021, 2026, 2031 (%)
Figure 108 China Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%
Figure 109 China Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Figure 110 China Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Figure 111 China Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Figure 112 China Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Figure 113 Japan Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%
Figure 114 Japan Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Figure 115 Japan Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Figure 116 Japan Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Figure 117 Japan Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Figure 118 India Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%
Figure 119 India Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Figure 120 India Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Figure 121 India Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Figure 122 India Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Figure 123 Rest of APAC Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%
Figure 124 Rest of APAC Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Figure 125 Rest of APAC Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Figure 126 Rest of APAC Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Figure 127 Rest of APAC Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Figure 128 Latin America Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%)
Figure 129 Latin America Epilepsy Therapeutics Market, by Type
Figure 130 Latin America Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Figure 131 Latin America Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Figure 132 Latin America Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Figure 133 Latin America Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Figure 134 Latin America Epilepsy Therapeutics Market, 2021, 2026, 2031 (%)
Figure 135 Brazil Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%
Figure 136 Brazil Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Figure 137 Brazil Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Figure 138 Brazil Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Figure 139 Brazil Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Figure 140 Mexico Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%
Figure 141 Mexico Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Figure 142 Mexico Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Figure 143 Mexico Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Figure 144 Mexico Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Figure 145 Rest of Latin America Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%
Figure 146 Rest of Latin America Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Figure 147 Rest of Latin America Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Figure 148 Rest of Latin America Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Figure 149 Rest of Latin America Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Figure 150 MEA Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%)
Figure 151 Middle East and Africa Epilepsy Therapeutics Market, by Type
Figure 152 MEA Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Figure 153 MEA Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Figure 154 MEA Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Figure 155 MEA Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Figure 156 MEA Epilepsy Therapeutics Market, 2021, 2026, 2031 (%)
Figure 157 GCC Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%
Figure 158 GCC Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Figure 159 GCC Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Figure 160 GCC Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Figure 161 GCC Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Figure 162 South Africa Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%
Figure 163 South Africa Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Figure 164 South Africa Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Figure 165 South Africa Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Figure 166 South Africa Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Figure 167 Rest of MEA Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%
Figure 168 Rest of MEA Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (V-Shaped Recovery)
Figure 169 Rest of Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (U-Shaped Recovery)
Figure 170 Rest of MEA Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (L-Shaped Recovery)
Figure 171 Rest of MEA Epilepsy Therapeutics Market (2021-2031) (USD Billion), AGR%, CAGR%), (W-Shaped Recovery)
Figure 172 Key players of Anti-Epileptic Drugs, 2020, %
Figure 173 UCB Pharma: Net Revenue, 2016-2020 (US$ million, AGR%)
Figure 174 UCB Pharma: Regional Revenue Shares, 2017-2019
Figure 175 UCB Pharma: Gross Profit, 2016-2020 (US$ million, AGR%)
Figure 176 UCB Pharma: R&D, 2016-2020 (US$ million, AGR%)
Figure 177 UCB Pharma: R&D, 2016-2020 (US$ million, AGR%)
Figure 178 Abcam: EBITDA Data, 2015-2019 (US$ million, AGR%)
Figure 179 Pfizer: Net Revenue, 2015-2019 (US$ million, AGR%)
Figure 180 Pfizer: Regional Revenue Shares, 2017-2019
Figure 181 Pfizer: Gross Profit, 2015-2019 (US$ million, AGR%)
Figure 182 Pfizer: R&D, 2015-2019 (US$ million, AGR%)
Figure 183 Eisai, Inc. : Net Revenue, 2015-2019 (US$ million, AGR%)
Figure 184 Eisai, Inc.: Regional Revenue Shares, 2017-2019
Figure 185 Eisai, Inc.: Gross Profit, 2015-2019 (US$ million, AGR%)
Figure 186 Eisai, Inc.: R&D, 2015-2019 (US$ million, AGR%)
Figure 187 GSK: Net Revenue, 2016-2020 (US$ million, AGR%)
Figure 188 GSK: Regional Revenue Shares, 2018-2020
Figure 189 GSK: Gross Profit, 2016-2020 (US$ million, AGR%)
Figure 190 GSK: R&D, 2016-2020 (US$ million, AGR%)
Figure 191 GW Pharma: Net Revenue, 2016-2020 (US$ million, AGR%)
Figure 192 GSK: Regional Revenue Shares, 2018-2019
Figure 193 GSK: R&D, 2016-2019 (US$ million, AGR%)
Figure 194 Sun Pharma: Net Revenue, 2016-2020 (US$ million, AGR%)
Figure 195 Sun Pharma: Gross Profit, 2016-2020 (US$ million, AGR%)
Figure 196 Sun Pharma: R&D, 2016-2020 (US$ million, AGR%)
Figure 197 Sun Pharma: R&D, 2016-2020 (US$ million, AGR%)
Figure 198 Sanofi: Net Revenue, 2016-2020 (US$ million, AGR%)
Figure 199 Sanofi: Regional Revenue Shares, 2018-2019
Figure 200 GSK: Gross Profit, 2016-2020 (US$ million, AGR%)
Figure 201 Sanofi: R&D, 2016-2020 (US$ million, AGR%)
Figure 202 Regional Market Values, 2020-2031
Figure 203 Regional Market, 2021, 2026, 2031 (%)
Companies Profiled in the Report:
Eisai, Inc.
GlaxoSmithKline (GSK)
GW Pharma
Pfizer
Ranbaxy (Acquired by Sun Pharma)
Sanofi
UCB Pharma
List of Companies Mentioned in the Report:
Angelini Pharma
Arvelle Therapeutics
Aventis Pharma Limited/Sanofi
Biogen
Dr. Reddy’s Laboratories
Eisai
Engage Therapeutics
GSK
GW Pharma Ltd
Janssen
Jazz Pharma
Marinus Pharma
Mylan
Novartis Pharmaceuticals
Otsuka Pharmaceuticals
Pfizer
Ranbaxy (UK) Limited a Sun Pharmaceutical Company
Sanofi
SK Life Science, Inc.
Takeda
UCB
Upjohn UK Limited
Veriton Pharma
Xenon Pharmaceuticals
Zentiva
Zogenix, Inc.
List of Organizations Mentioned in the Report:
Australian Department of Health
Center for Biologics Evaluation and Research (CBER)
Center for Drug Evaluation and Research (CDER)
Centers for Disease Control and Prevention (CDC)
China Food and Drug Administration (CFDA)
Epilepsy Foundation
European Medicines Agency (EMEA)
Florey Institute of Neuroscience and Mental Health
Indian Epilepsy Association (IEA)
Indian Epilepsy Society (IES)
International Bureau for Epilepsy (IBE)
International League Against Epilepsy (ILAE)
Italian Pharmaceutical Agency and Federal Institute for Drugs and Medical Devices
Medicines and Healthcare Products Regulatory Agency (MHRA)
Ministry of Health, Labor and Welfare (MHLW)
National Administration of Medicines, Food and Medical Technology (ANMAT)
National Agency for Food and Drug Administration and Control
National Health Service (NHS)
National Institute of Surveillance of Medicines and Foods (INVIMA)
National Sanitary Surveillance Agency (ANVISA)
Pan American Health Organization (PAHO)
Pharmacy and Poisons Board (Kenya)
Public Health England
South African Health Products Regulatory Authority (SAHPRA)
Therapeutic Goods Administration (TGA)
U.S. Food and Drug Administration
World Health Organization (WHO)
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
